Skip to main content

MoneyWorks4Me

Strides Pharma Science informs about press release

22 May 2024 Evaluate
Strides Pharma Science has informed that it enclosed Press Release issued by the Company titled: ‘Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10 mL’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..